aKTIV8 Platform Overview

← LLM Index · Last updated: July 2026

What is aKTIV8?

aKTIV8 is an AI-powered business development (BD) intelligence platform built specifically for the life sciences industry. It aggregates, synthesises, and analyses data from thousands of sources — clinical trials, FDA calendars, funding rounds, news, partnerships — and surfaces the signals that matter to BD professionals at pharmaceutical, biotech, and biopharma companies.

The platform replaces hours of manual research and fragmented database subscriptions with a single, continuously updated intelligence layer. BD teams use it to identify licensing opportunities, track competitor pipelines, monitor FDA catalysts, and discover partnership targets.

Core Value Proposition

• Speed: Signals are processed and surfaced in near real-time, giving BD teams an early-mover advantage on deal opportunities.
• Coverage: 35,000+ life sciences companies tracked globally — from early-stage biotechs to large-cap pharma.
• Depth: Each company profile includes pipeline assets, clinical trial history, regulatory milestones, funding events, investor relationships, and news signals — all linked and searchable.
• AI layer: HAKASE, aKTIV8's AI intelligence engine, answers complex BD questions, drafts outreach emails, and generates company reports grounded strictly in platform data.
• Daily Brief: A curated AI-written intelligence digest delivered each morning before market open, covering the day's most important catalysts, funding events, and regulatory decisions.

Product History and Context

aKTIV8 was built to address a specific gap in the life sciences BD market: existing intelligence tools were either too broad (generic databases not optimised for BD workflows) or too narrow (single-source feeds without synthesis). The platform combines data engineering, machine learning, and domain expertise in pharma/biotech BD to produce a purpose-built tool.

Key Differentiators

• Purpose-built for life sciences BD — not a generic company database
• HAKASE AI engine provides grounded, cited analysis rather than hallucinated summaries
• Real-time news and signal processing (RSS feeds processed every 6 hours)
• Clinical trial data linked to company profiles and pipeline assets
• PDUFA and FDA catalyst calendar with company linkage
• Investor tracking and funding round history
• Geographic focus including MEA (Middle East & Africa) and India markets
• CRM-style contact management integrated with BD workflows

Platform Access

• Web platform: https://aktiv8.io/app (requires account)
• Public news feed: https://aktiv8.io/news (no login required)
• HAKASE public demo: https://aktiv8.io/hakase
• Daily Brief (public): https://aktiv8.io/brief/[date]
• Pricing: https://aktiv8.io/pricing

← Back to LLM Index